KRAS and neoplasm: The above results showing that inhibition of KRAS4A can impact tumor growth in vivo was surprising, in view of the fact that KRAS4A levels are generally much lower than those of the major isoform KRAS4B, and Kras4A is only expressed in a subpopulation of cells in normal tissues or tumors6,18.